0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global HIV & AIDS Diagnostics Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-26M5934
Home | Market Reports | Health| Nursing
Global HIV AIDS Diagnostics Market Insights Forecast to 2028
BUY CHAPTERS

Global HIV & AIDS Diagnostics Market Research Report 2025

Code: QYRE-Auto-26M5934
Report
September 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

HIV & AIDS Diagnostics Market Size

The global market for HIV & AIDS Diagnostics was valued at US$ 1928 million in the year 2024 and is projected to reach a revised size of US$ 2958 million by 2031, growing at a CAGR of 6.4% during the forecast period.

HIV & AIDS Diagnostics Market

HIV & AIDS Diagnostics Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for HIV & AIDS Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HIV & AIDS Diagnostics.
The HIV & AIDS Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global HIV & AIDS Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HIV & AIDS Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of HIV & AIDS Diagnostics Market Report

Report Metric Details
Report Name HIV & AIDS Diagnostics Market
Accounted market size in year US$ 1928 million
Forecasted market size in 2031 US$ 2958 million
CAGR 6.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Kits and Reagents
  • Instruments
  • Others
Segment by Application
  • Hospitals
  • Private Diagnostic Laboratories
  • Academic and Research Institutes
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Siemens Healthineers, Bio-Rad, Abbott Laboratories, OraSure Technologies, F. Hoffmann-La Roche, Hologic, Abbott, Chembio Diagnostic Systems, Becton, Dickinson and Company, Danaher Corporation(Cepheid)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of HIV & AIDS Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is HIV & AIDS Diagnostics Market growing?

Ans: The HIV & AIDS Diagnostics Market witnessing a CAGR of 6.4% during the forecast period 2025-2031.

What is the HIV & AIDS Diagnostics Market size in 2031?

Ans: The HIV & AIDS Diagnostics Market size in 2031 will be US$ 2958 million.

Who are the main players in the HIV & AIDS Diagnostics Market report?

Ans: The main players in the HIV & AIDS Diagnostics Market are Siemens Healthineers, Bio-Rad, Abbott Laboratories, OraSure Technologies, F. Hoffmann-La Roche, Hologic, Abbott, Chembio Diagnostic Systems, Becton, Dickinson and Company, Danaher Corporation(Cepheid)

What are the Application segmentation covered in the HIV & AIDS Diagnostics Market report?

Ans: The Applications covered in the HIV & AIDS Diagnostics Market report are Hospitals, Private Diagnostic Laboratories, Academic and Research Institutes, Others

What are the Type segmentation covered in the HIV & AIDS Diagnostics Market report?

Ans: The Types covered in the HIV & AIDS Diagnostics Market report are Kits and Reagents, Instruments, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HIV & AIDS Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Kits and Reagents
1.2.3 Instruments
1.2.4 Others
1.3 Market by Application
1.3.1 Global HIV & AIDS Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Private Diagnostic Laboratories
1.3.4 Academic and Research Institutes
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global HIV & AIDS Diagnostics Market Perspective (2020-2031)
2.2 Global HIV & AIDS Diagnostics Growth Trends by Region
2.2.1 Global HIV & AIDS Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 HIV & AIDS Diagnostics Historic Market Size by Region (2020-2025)
2.2.3 HIV & AIDS Diagnostics Forecasted Market Size by Region (2026-2031)
2.3 HIV & AIDS Diagnostics Market Dynamics
2.3.1 HIV & AIDS Diagnostics Industry Trends
2.3.2 HIV & AIDS Diagnostics Market Drivers
2.3.3 HIV & AIDS Diagnostics Market Challenges
2.3.4 HIV & AIDS Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top HIV & AIDS Diagnostics Players by Revenue
3.1.1 Global Top HIV & AIDS Diagnostics Players by Revenue (2020-2025)
3.1.2 Global HIV & AIDS Diagnostics Revenue Market Share by Players (2020-2025)
3.2 Global HIV & AIDS Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by HIV & AIDS Diagnostics Revenue
3.4 Global HIV & AIDS Diagnostics Market Concentration Ratio
3.4.1 Global HIV & AIDS Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HIV & AIDS Diagnostics Revenue in 2024
3.5 Global Key Players of HIV & AIDS Diagnostics Head office and Area Served
3.6 Global Key Players of HIV & AIDS Diagnostics, Product and Application
3.7 Global Key Players of HIV & AIDS Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 HIV & AIDS Diagnostics Breakdown Data by Type
4.1 Global HIV & AIDS Diagnostics Historic Market Size by Type (2020-2025)
4.2 Global HIV & AIDS Diagnostics Forecasted Market Size by Type (2026-2031)
5 HIV & AIDS Diagnostics Breakdown Data by Application
5.1 Global HIV & AIDS Diagnostics Historic Market Size by Application (2020-2025)
5.2 Global HIV & AIDS Diagnostics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America HIV & AIDS Diagnostics Market Size (2020-2031)
6.2 North America HIV & AIDS Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America HIV & AIDS Diagnostics Market Size by Country (2020-2025)
6.4 North America HIV & AIDS Diagnostics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe HIV & AIDS Diagnostics Market Size (2020-2031)
7.2 Europe HIV & AIDS Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe HIV & AIDS Diagnostics Market Size by Country (2020-2025)
7.4 Europe HIV & AIDS Diagnostics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific HIV & AIDS Diagnostics Market Size (2020-2031)
8.2 Asia-Pacific HIV & AIDS Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific HIV & AIDS Diagnostics Market Size by Region (2020-2025)
8.4 Asia-Pacific HIV & AIDS Diagnostics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America HIV & AIDS Diagnostics Market Size (2020-2031)
9.2 Latin America HIV & AIDS Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America HIV & AIDS Diagnostics Market Size by Country (2020-2025)
9.4 Latin America HIV & AIDS Diagnostics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa HIV & AIDS Diagnostics Market Size (2020-2031)
10.2 Middle East & Africa HIV & AIDS Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa HIV & AIDS Diagnostics Market Size by Country (2020-2025)
10.4 Middle East & Africa HIV & AIDS Diagnostics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Siemens Healthineers
11.1.1 Siemens Healthineers Company Details
11.1.2 Siemens Healthineers Business Overview
11.1.3 Siemens Healthineers HIV & AIDS Diagnostics Introduction
11.1.4 Siemens Healthineers Revenue in HIV & AIDS Diagnostics Business (2020-2025)
11.1.5 Siemens Healthineers Recent Development
11.2 Bio-Rad
11.2.1 Bio-Rad Company Details
11.2.2 Bio-Rad Business Overview
11.2.3 Bio-Rad HIV & AIDS Diagnostics Introduction
11.2.4 Bio-Rad Revenue in HIV & AIDS Diagnostics Business (2020-2025)
11.2.5 Bio-Rad Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Details
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories HIV & AIDS Diagnostics Introduction
11.3.4 Abbott Laboratories Revenue in HIV & AIDS Diagnostics Business (2020-2025)
11.3.5 Abbott Laboratories Recent Development
11.4 OraSure Technologies
11.4.1 OraSure Technologies Company Details
11.4.2 OraSure Technologies Business Overview
11.4.3 OraSure Technologies HIV & AIDS Diagnostics Introduction
11.4.4 OraSure Technologies Revenue in HIV & AIDS Diagnostics Business (2020-2025)
11.4.5 OraSure Technologies Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Details
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche HIV & AIDS Diagnostics Introduction
11.5.4 F. Hoffmann-La Roche Revenue in HIV & AIDS Diagnostics Business (2020-2025)
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 Hologic
11.6.1 Hologic Company Details
11.6.2 Hologic Business Overview
11.6.3 Hologic HIV & AIDS Diagnostics Introduction
11.6.4 Hologic Revenue in HIV & AIDS Diagnostics Business (2020-2025)
11.6.5 Hologic Recent Development
11.7 Abbott
11.7.1 Abbott Company Details
11.7.2 Abbott Business Overview
11.7.3 Abbott HIV & AIDS Diagnostics Introduction
11.7.4 Abbott Revenue in HIV & AIDS Diagnostics Business (2020-2025)
11.7.5 Abbott Recent Development
11.8 Chembio Diagnostic Systems
11.8.1 Chembio Diagnostic Systems Company Details
11.8.2 Chembio Diagnostic Systems Business Overview
11.8.3 Chembio Diagnostic Systems HIV & AIDS Diagnostics Introduction
11.8.4 Chembio Diagnostic Systems Revenue in HIV & AIDS Diagnostics Business (2020-2025)
11.8.5 Chembio Diagnostic Systems Recent Development
11.9 Becton, Dickinson and Company
11.9.1 Becton, Dickinson and Company Company Details
11.9.2 Becton, Dickinson and Company Business Overview
11.9.3 Becton, Dickinson and Company HIV & AIDS Diagnostics Introduction
11.9.4 Becton, Dickinson and Company Revenue in HIV & AIDS Diagnostics Business (2020-2025)
11.9.5 Becton, Dickinson and Company Recent Development
11.10 Danaher Corporation(Cepheid)
11.10.1 Danaher Corporation(Cepheid) Company Details
11.10.2 Danaher Corporation(Cepheid) Business Overview
11.10.3 Danaher Corporation(Cepheid) HIV & AIDS Diagnostics Introduction
11.10.4 Danaher Corporation(Cepheid) Revenue in HIV & AIDS Diagnostics Business (2020-2025)
11.10.5 Danaher Corporation(Cepheid) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global HIV & AIDS Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Kits and Reagents
 Table 3. Key Players of Instruments
 Table 4. Key Players of Others
 Table 5. Global HIV & AIDS Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global HIV & AIDS Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global HIV & AIDS Diagnostics Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global HIV & AIDS Diagnostics Market Share by Region (2020-2025)
 Table 9. Global HIV & AIDS Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global HIV & AIDS Diagnostics Market Share by Region (2026-2031)
 Table 11. HIV & AIDS Diagnostics Market Trends
 Table 12. HIV & AIDS Diagnostics Market Drivers
 Table 13. HIV & AIDS Diagnostics Market Challenges
 Table 14. HIV & AIDS Diagnostics Market Restraints
 Table 15. Global HIV & AIDS Diagnostics Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global HIV & AIDS Diagnostics Market Share by Players (2020-2025)
 Table 17. Global Top HIV & AIDS Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV & AIDS Diagnostics as of 2024)
 Table 18. Ranking of Global Top HIV & AIDS Diagnostics Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by HIV & AIDS Diagnostics Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of HIV & AIDS Diagnostics, Headquarters and Area Served
 Table 21. Global Key Players of HIV & AIDS Diagnostics, Product and Application
 Table 22. Global Key Players of HIV & AIDS Diagnostics, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global HIV & AIDS Diagnostics Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global HIV & AIDS Diagnostics Revenue Market Share by Type (2020-2025)
 Table 26. Global HIV & AIDS Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global HIV & AIDS Diagnostics Revenue Market Share by Type (2026-2031)
 Table 28. Global HIV & AIDS Diagnostics Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global HIV & AIDS Diagnostics Revenue Market Share by Application (2020-2025)
 Table 30. Global HIV & AIDS Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global HIV & AIDS Diagnostics Revenue Market Share by Application (2026-2031)
 Table 32. North America HIV & AIDS Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America HIV & AIDS Diagnostics Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America HIV & AIDS Diagnostics Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe HIV & AIDS Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe HIV & AIDS Diagnostics Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe HIV & AIDS Diagnostics Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific HIV & AIDS Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific HIV & AIDS Diagnostics Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific HIV & AIDS Diagnostics Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America HIV & AIDS Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America HIV & AIDS Diagnostics Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America HIV & AIDS Diagnostics Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa HIV & AIDS Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa HIV & AIDS Diagnostics Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa HIV & AIDS Diagnostics Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Siemens Healthineers Company Details
 Table 48. Siemens Healthineers Business Overview
 Table 49. Siemens Healthineers HIV & AIDS Diagnostics Product
 Table 50. Siemens Healthineers Revenue in HIV & AIDS Diagnostics Business (2020-2025) & (US$ Million)
 Table 51. Siemens Healthineers Recent Development
 Table 52. Bio-Rad Company Details
 Table 53. Bio-Rad Business Overview
 Table 54. Bio-Rad HIV & AIDS Diagnostics Product
 Table 55. Bio-Rad Revenue in HIV & AIDS Diagnostics Business (2020-2025) & (US$ Million)
 Table 56. Bio-Rad Recent Development
 Table 57. Abbott Laboratories Company Details
 Table 58. Abbott Laboratories Business Overview
 Table 59. Abbott Laboratories HIV & AIDS Diagnostics Product
 Table 60. Abbott Laboratories Revenue in HIV & AIDS Diagnostics Business (2020-2025) & (US$ Million)
 Table 61. Abbott Laboratories Recent Development
 Table 62. OraSure Technologies Company Details
 Table 63. OraSure Technologies Business Overview
 Table 64. OraSure Technologies HIV & AIDS Diagnostics Product
 Table 65. OraSure Technologies Revenue in HIV & AIDS Diagnostics Business (2020-2025) & (US$ Million)
 Table 66. OraSure Technologies Recent Development
 Table 67. F. Hoffmann-La Roche Company Details
 Table 68. F. Hoffmann-La Roche Business Overview
 Table 69. F. Hoffmann-La Roche HIV & AIDS Diagnostics Product
 Table 70. F. Hoffmann-La Roche Revenue in HIV & AIDS Diagnostics Business (2020-2025) & (US$ Million)
 Table 71. F. Hoffmann-La Roche Recent Development
 Table 72. Hologic Company Details
 Table 73. Hologic Business Overview
 Table 74. Hologic HIV & AIDS Diagnostics Product
 Table 75. Hologic Revenue in HIV & AIDS Diagnostics Business (2020-2025) & (US$ Million)
 Table 76. Hologic Recent Development
 Table 77. Abbott Company Details
 Table 78. Abbott Business Overview
 Table 79. Abbott HIV & AIDS Diagnostics Product
 Table 80. Abbott Revenue in HIV & AIDS Diagnostics Business (2020-2025) & (US$ Million)
 Table 81. Abbott Recent Development
 Table 82. Chembio Diagnostic Systems Company Details
 Table 83. Chembio Diagnostic Systems Business Overview
 Table 84. Chembio Diagnostic Systems HIV & AIDS Diagnostics Product
 Table 85. Chembio Diagnostic Systems Revenue in HIV & AIDS Diagnostics Business (2020-2025) & (US$ Million)
 Table 86. Chembio Diagnostic Systems Recent Development
 Table 87. Becton, Dickinson and Company Company Details
 Table 88. Becton, Dickinson and Company Business Overview
 Table 89. Becton, Dickinson and Company HIV & AIDS Diagnostics Product
 Table 90. Becton, Dickinson and Company Revenue in HIV & AIDS Diagnostics Business (2020-2025) & (US$ Million)
 Table 91. Becton, Dickinson and Company Recent Development
 Table 92. Danaher Corporation(Cepheid) Company Details
 Table 93. Danaher Corporation(Cepheid) Business Overview
 Table 94. Danaher Corporation(Cepheid) HIV & AIDS Diagnostics Product
 Table 95. Danaher Corporation(Cepheid) Revenue in HIV & AIDS Diagnostics Business (2020-2025) & (US$ Million)
 Table 96. Danaher Corporation(Cepheid) Recent Development
 Table 97. Research Programs/Design for This Report
 Table 98. Key Data Information from Secondary Sources
 Table 99. Key Data Information from Primary Sources
 Table 100. Authors List of This Report


List of Figures
 Figure 1. HIV & AIDS Diagnostics Picture
 Figure 2. Global HIV & AIDS Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global HIV & AIDS Diagnostics Market Share by Type: 2024 VS 2031
 Figure 4. Kits and Reagents Features
 Figure 5. Instruments Features
 Figure 6. Others Features
 Figure 7. Global HIV & AIDS Diagnostics Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global HIV & AIDS Diagnostics Market Share by Application: 2024 VS 2031
 Figure 9. Hospitals Case Studies
 Figure 10. Private Diagnostic Laboratories Case Studies
 Figure 11. Academic and Research Institutes Case Studies
 Figure 12. Others Case Studies
 Figure 13. HIV & AIDS Diagnostics Report Years Considered
 Figure 14. Global HIV & AIDS Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global HIV & AIDS Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global HIV & AIDS Diagnostics Market Share by Region: 2024 VS 2031
 Figure 17. Global HIV & AIDS Diagnostics Market Share by Players in 2024
 Figure 18. Global Top HIV & AIDS Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV & AIDS Diagnostics as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by HIV & AIDS Diagnostics Revenue in 2024
 Figure 20. North America HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America HIV & AIDS Diagnostics Market Share by Country (2020-2031)
 Figure 22. United States HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe HIV & AIDS Diagnostics Market Share by Country (2020-2031)
 Figure 26. Germany HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific HIV & AIDS Diagnostics Market Share by Region (2020-2031)
 Figure 34. China HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America HIV & AIDS Diagnostics Market Share by Country (2020-2031)
 Figure 42. Mexico HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa HIV & AIDS Diagnostics Market Share by Country (2020-2031)
 Figure 46. Turkey HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Siemens Healthineers Revenue Growth Rate in HIV & AIDS Diagnostics Business (2020-2025)
 Figure 50. Bio-Rad Revenue Growth Rate in HIV & AIDS Diagnostics Business (2020-2025)
 Figure 51. Abbott Laboratories Revenue Growth Rate in HIV & AIDS Diagnostics Business (2020-2025)
 Figure 52. OraSure Technologies Revenue Growth Rate in HIV & AIDS Diagnostics Business (2020-2025)
 Figure 53. F. Hoffmann-La Roche Revenue Growth Rate in HIV & AIDS Diagnostics Business (2020-2025)
 Figure 54. Hologic Revenue Growth Rate in HIV & AIDS Diagnostics Business (2020-2025)
 Figure 55. Abbott Revenue Growth Rate in HIV & AIDS Diagnostics Business (2020-2025)
 Figure 56. Chembio Diagnostic Systems Revenue Growth Rate in HIV & AIDS Diagnostics Business (2020-2025)
 Figure 57. Becton, Dickinson and Company Revenue Growth Rate in HIV & AIDS Diagnostics Business (2020-2025)
 Figure 58. Danaher Corporation(Cepheid) Revenue Growth Rate in HIV & AIDS Diagnostics Business (2020-2025)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Spatial Transcriptomics Service Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-29Y19622
Thu Oct 02 00:00:00 UTC 2025

Add to Cart

Global Internet Intelligent Elderly Care Service Platform Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-25O19660
Thu Oct 02 00:00:00 UTC 2025

Add to Cart

Global Spatial Epigenomics Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-4D20026
Thu Oct 02 00:00:00 UTC 2025

Add to Cart

Global Plant Metabolomics Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-32Q19784
Thu Oct 02 00:00:00 UTC 2025

Add to Cart